Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
macrolide |
| gptkbp:approvalYear |
2011
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:A07AA12
|
| gptkbp:brand |
gptkb:Dificid
|
| gptkbp:CASNumber |
873857-62-6
|
| gptkbp:chemicalFormula |
C52H74Cl2O18
|
| gptkbp:discoveredBy |
gptkb:Sanofi
|
| gptkbp:eliminationHalfLife |
11.7 hours
|
| gptkbp:excretion |
feces
|
| https://www.w3.org/2000/01/rdf-schema#label |
fidaxomicin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits RNA polymerase
|
| gptkbp:metabolism |
minimal
|
| gptkbp:molecularWeight |
1058.04 g/mol
|
| gptkbp:origin |
fermentation product of Actinoplanes deccanensis
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
88%
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting abdominal pain gastrointestinal hemorrhage |
| gptkbp:synonym |
lipiarmycin A3
tiacumicin B |
| gptkbp:usedFor |
gptkb:Clostridioides_difficile_infection
|
| gptkbp:bfsParent |
gptkb:Clostridioides_difficile_infection
|
| gptkbp:bfsLayer |
5
|